Faculty

Back to Index
Janet Laurie Sobell, PhD
Associate Professor of Research Psychiatry & The Behavioral Sciences
Psychiatry and The Behavioral Sciences
ZNI 401 1501 San Pablo Street Health Sciences Campus Los Angeles
+1 424 240 9310

Publications

. View in: PubMed

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Transl Psychiatry. 2017 Jan 10; 7(1):e993. View in: PubMed

Substance use associated with short sleep duration in patients with schizophrenia or schizoaffective disorder. Am J Med Genet B Neuropsychiatr Genet. 2016 Jun; 171(4):525-33. View in: PubMed

LINE1 insertions as a genomic risk factor for schizophrenia: Preliminary evidence from an affected family. Am J Med Genet B Neuropsychiatr Genet. 2016 Jun; 171(4):534-45. View in: PubMed

Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis. Am J Med Genet B Neuropsychiatr Genet. 2016 Jun; 171(4):495-505. View in: PubMed

Traumatic brain injury and bipolar psychosis in the Genomic Psychiatry Cohort. Am J Med Genet B Neuropsychiatr Genet. 2016 Jun; 171(4):506-12. View in: PubMed

Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study. JAMA Psychiatry. 2016 May 01; 73(5):506-14. View in: PubMed

Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study. JAMA Psychiatry. 2016 May 1; 73(5):506-14. View in: PubMed

Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis. Am J Med Genet B Neuropsychiatr Genet. 2016 06; 171(4):495-505. View in: PubMed

Substance use associated with short sleep duration in patients with schizophrenia or schizoaffective disorder. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep 8. View in: PubMed

Transposable elements and psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2014 Apr; 165B(3):201-16. View in: PubMed

Transposable elements and psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2014 Apr; 165(3):201-16. View in: PubMed

Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014 Mar; 71(3):248-54. View in: PubMed

Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014 Mar 1; 71(3):248-54. View in: PubMed

The genomic psychiatry cohort: partners in discovery. Am J Med Genet B Neuropsychiatr Genet. 2013 Jun; 162B(4):306-12. View in: PubMed

A system architecture for sharing de-identified, research-ready brain scans and health information across clinical imaging centers. Stud Health Technol Inform. 2012; 175:19-28. View in: PubMed

Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry. 2006 Jul 15; 60(2):152-62. View in: PubMed

Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):23-7. View in: PubMed

Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5; 139B(1):23-7. View in: PubMed

Multiple missense mutations in the diazepam binding inhibitor (DBI) gene identified in schizophrenia but lack of disease association. Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15; 125B(1):10-9. View in: PubMed

Genetics and etiopathophysiology of schizophrenia. Mayo Clin Proc. 2002 Oct; 77(10):1068-82. View in: PubMed

Alteration of branch site consensus sequence and enhanced pre-mRNA splicing of an NMDAR1 intron not associated with schizophrenia. Am J Med Genet. 2002 Aug 8; 114(6):631-6. View in: PubMed

Alteration of branch site consensus sequence and enhanced pre-mRNA splicing of an NMDAR1 intron not associated with schizophrenia. Am J Med Genet. 2002 Aug 08; 114(6):631-6. View in: PubMed

Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry. 2001 May; 6(3):274-84. View in: PubMed

Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia. Am J Med Genet. 2000 Jun 12; 96(3):404-6. View in: PubMed

Variants in the alpha2A AR adrenergic receptor gene in psychiatric patients. Am J Med Genet. 1998 Sep 07; 81(5):405-10. View in: PubMed

Variants in the alpha2A AR adrenergic receptor gene in psychiatric patients. Am J Med Genet. 1998 Sep 7; 81(5):405-10. View in: PubMed

Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid. Am J Med Genet. 1998 Mar 28; 81(2):172-8. View in: PubMed

Gly(247)-->Asp proenkephalin A mutation is rare in schizophrenia populations. Am J Med Genet. 1997 Apr 18; 74(2):213-5. View in: PubMed

Screening the monoamine oxidase B gene in 100 male patients with schizophrenia: a cluster of polymorphisms in African-Americans but lack of functionally significant sequence changes. Am J Med Genet. 1997 Feb 21; 74(1):44-9. View in: PubMed

Identification of a missense mutation and several polymorphisms in the proenkephalin A gene of schizophrenic patients. Am J Med Genet. 1996 Sep 20; 67(5):459-67. View in: PubMed

Genotype-to-phenotype analysis: search for clinical characteristics of a missense change in the GABAA-beta 1 receptor gene. Am J Med Genet. 1996 Feb 16; 67(1):81-4. View in: PubMed

Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics: identification of polymorphisms but lack of functionally significant sequence changes. Am J Med Genet. 1995 Apr 24; 60(2):165-71. View in: PubMed

The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease. Hum Mol Genet. 1995 Apr; 4(4):507-14. View in: PubMed

S311C D2DR variant: no association with schizophrenia. Lancet. 1994 Aug 27; 344(8922):621-2. View in: PubMed

Screening the dystrophin gene suggests a high rate of polymorphism in general but no exonic deletions in schizophrenics. Am J Med Genet. 1994 Mar 15; 54(1):1-4. View in: PubMed

Search for mutations in the beta 1 GABAA receptor subunit gene in patients with schizophrenia. Am J Med Genet. 1994 Mar 15; 54(1):12-20. View in: PubMed

A common exonic polymorphism in the human D5 dopamine receptor gene. Hum Genet. 1993 Dec; 92(6):633-4. View in: PubMed

APP mutations and schizophrenia. Biol Psychiatry. 1993 Nov 15; 34(10):739-40. View in: PubMed

Dopamine D4 receptor variants in unrelated schizophrenic cases and controls. Am J Med Genet. 1993 Jul 15; 48(2):90-3. View in: PubMed

Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene. Am J Med Genet. 1993 May 1; 48(1):28-35. View in: PubMed

Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene. Am J Med Genet. 1993 May 01; 48(1):28-35. View in: PubMed

Eight novel polymorphisms in the dystrophin gene of African-Americans: the rate of polymorphism is high. Hum Mutat. 1993; 2(6):485-8. View in: PubMed

Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics. 1992 Jan; 12(1):1-6. View in: PubMed

Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics. 1991 Sep; 11(1):8-14. View in: PubMed

A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria. Mayo Clin Proc. 1989 Nov; 64(11):1361-72. View in: PubMed

Application of DNA-based diagnosis to patient care: the example of hemophilia A. Mayo Clin Proc. 1987 May; 62(5):387-404. View in: PubMed

Powered bySC CTSI